Compare CUE & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CUE | IH |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.5M | 58.8M |
| IPO Year | 2017 | 2020 |
| Metric | CUE | IH |
|---|---|---|
| Price | $25.60 | $1.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $88.00 | N/A |
| AVG Volume (30 Days) | ★ 353.1K | 4.5K |
| Earning Date | 11-11-2026 | 09-29-2026 |
| Dividend Yield | N/A | ★ 8.73% |
| EPS Growth | ★ 61.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,466,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.30 |
| Revenue Growth | ★ 195.75 | N/A |
| 52 Week Low | $0.17 | $1.11 |
| 52 Week High | $45.50 | $3.09 |
| Indicator | CUE | IH |
|---|---|---|
| Relative Strength Index (RSI) | 42.64 | 41.04 |
| Support Level | $23.51 | N/A |
| Resistance Level | $33.11 | $1.38 |
| Average True Range (ATR) | 4.91 | 0.04 |
| MACD | -0.83 | 0.00 |
| Stochastic Oscillator | 11.41 | 33.33 |
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.